Americann Inc
General ticker "ACAN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $504.2K
Americann Inc does not follow the US Stock Market performance with the rate: -45.2%.
Estimated limits based on current volatility of 11.7%: low 0.02$, high 0.03$
Factors to consider:
- Current price 89.4% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [0.20$, 0.48$]
- 2024-09-29 to 2025-09-29 estimated range: [0.24$, 0.54$]
Financial Metrics affecting the ACAN estimates:
- Negative: Non-GAAP EPS, $ of -0.03 <= 0.10
- Negative: negative Net income
- Positive: Operating profit margin, % of 23.97 > 19.51
- Negative: Industry operating cash flow per share per price (median), % of -11.04 <= 3.85
Short-term ACAN quotes
Long-term ACAN plot with estimates
Financial data
| YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|
| Operating Revenue | $2.03MM | $2.93MM | $2.55MM |
| Operating Expenses | $1.98MM | $2.45MM | $1.94MM |
| Operating Income | $0.04MM | $0.48MM | $0.61MM |
| Non-Operating Income | $-0.91MM | $-0.66MM | $-0.71MM |
| Interest Expense | $0.93MM | $0.67MM | $0.71MM |
| Income(Loss) | $-0.86MM | $-0.17MM | $-0.09MM |
| Profit(Loss) | $-0.86MM | $-0.17MM | $-0.09MM |
| Stockholders Equity | $5.51MM | $5.80MM | $5.71MM |
| Inventory | $0.26MM | $0.00MM | $0.01MM |
| Assets | $15.06MM | $15.44MM | $15.15MM |
| Operating Cash Flow | $-0.28MM | $0.85MM | $0.58MM |
| Capital expenditure | $0.09MM | $0.25MM | $0.28MM |
| Investing Cash Flow | $-0.06MM | $-0.20MM | $-0.64MM |
| Financing Cash Flow | $0.85MM | $0.00MM | $-0.15MM |
| Earnings Per Share* | $-0.07 | $-0.03 | $-0.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.